Confirm or change your preferred country of delivery, language or currency. If you do this when logged in, your preferences will be remembered on your MZAccount. You can change them at any time by clicking the arrow at the top of the page.
Your location affects the final order price. It may vary depending on the amount of VAT rate applicable at your current location.
|Servings: 180 caps.|
SARM MK-2866 Ostarine is a product based on ostarine, a compound called ((2S) -3- (4-cyanophenoxy) -N- [4-cyano-3- (trifluoromethyl) phenyl] -2-hydroxy-2-methylpropanamide). Ostarine, known as Enobosarm, GTx-024, MK-2866 or S-22, is a substance belonging to the SARM category.
((2S) -3- (4-cyanophenoxy) -N- [4-cyano-3- (trifluoromethyl) phenyl] -2-hydroxy-2-methylpropanamide) is not sensitive to the enzymes catalyzing reductases and aromatase. As a result, it minimizes the side effects that are attributed to excessive amounts of testosterone needed to achieve a similar anabolism. Probably due to the slight influence on aromatase activity, it may slightly increase the level of estrogen. It does not cause androgenic alopecia, acne or enlargement of the prostate gland. By affecting the collagen synthesis process, it often leads to improved joint and skin condition.
Ostarine, as a selective androgen receptor modulator, shows a strong, comparable to testosterone anabolic activity, with significantly reduced androgenic activity. It intensifies the processes of muscle tissue synthesis and improves skeletal mineralization.
MK-2866 consumed in a specified dose allows a noticeable increase in the muscle strength and mass as well as a significant loss of fat. It improves the aesthetics of the figure, emphasizes it thanks to vascularisation and muscle filling. Practically, it does not affect the level of free testosterone, but may tend to be slightly blocked depending on the dose and the length of taking. It does not affect the libido negatively. It significantly affects the lipid profile, leading in particular to lowering the total cholesterol level. The product is characterized by high bioavailability and the safety of use. This SARM is characterized by high anabolic strength at low androgenic potential. The product effectively enhances the muscle growth, loss of the excess fat tissue and skeletal mineralization.
Ostarine is a popular and safe means of group SARM. In most cases, the use of a dose of about 5-10 mg per day of hormone does not lock the axis and does not require so. unlock. It should be noted, however, that every body is different and reacts differently to a given substance. Beginners recommend dosage of 10 mg per day. Advanced suggest a week of time to increase the dose to 20 mg, and if necessary even to 30 and 40 mg per day. As practice shows, a dose of 10 mg a day is sufficient for therapeutic effect on the joints and can safely be used continuously up to 4-6 months.
200 characters left for the review to be rated.
MK-2866 ((2S) -3- (4-cyanophenoxy) -N- [4-cyano-3- (trifluoromethyl) phenyl] -2-hydroxy-2-methylpropanamide, ostaryna) as a selective androgen receptor modulator has a strong, comparable to testosterone anabolic effects, while reduced androgenic effect. It enhances the processes of creating muscle tissue and improves bone mineralization.
The clinical dose (3 mg / day) - administration for 12 weeks of Ostarine leads to an increase in the total mass and muscle strength. It does not cause changes in the concentrations: free testosterone, DHT, estradiol, FSH and LH. This leads to a significant decrease in the hormone-binding globulin (SHBG), which is associated with a reduction in the amount of total testosterone. Without affecting insulin levels, lowers fasting blood glucose and decreases levels of insulin, which improves the activation of anabolic processes in the body and reduces the risk of type 2 diabetes reduces serum triglycerides, total cholesterol, HDL cholesterol and improves the LDL / HDL ratio, reducing the risk of cardiovascular disease.